INTRODUCTION
Lymphangiomatosis is a benign disorder of congenital malformations of lymphatic development occurring before the 20 th week of gestation. [1] It is characterized by the presence of proliferative differentiated lymphatic tissues called lymphangiomas [1] infiltrating adjacent organs mainly the pulmonary and skeletal systems, with poor prognosis in children as compared to adults. [1, 2] Due to its rarity, wide spectrum of clinical features, and a lack of randomized clinical trials apart from a few case reports, it has been difficult to diagnose and establish a definitive treatment protocol. We report this case to highlight its rare unilateral, multi-organ
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massive right pleural effusion causing collapse of the right lung with contralateral mediastinal shift and ascites [ Figure 2 ]. Computed tomography (CT) scan of chest, abdomen and pelvis showed gross right pleural effusion, moderate ascites, hydrocele, lytic lesions involving right ilium, ala of sacrum [ Figure 3 ], ischium, pubic bone, shaft of the right femur, and D-12 to S-2 vertebrae. Angiography of lower limbs showed no arteriovenous malformation. Pleural tapping showed chylous effusion leading to drainage of 1-1.5 L fluid per day. Image-guided trucut biopsy of pleural peel and lung tissue showed chronic inflammation and was negative for malignancy.
Magnetic resonance imaging (MRI) of lower limbs [ Figure 4 ] showed the involvement of soft tissue and muscles of the right hip, thigh, knee, and right hemiscrotum with lymphatic changes within. Trucut biopsy from right thigh showed closely packed small vascular channels lined by flattened endothelial cells favoring lymphangiomatosis [ Figure 5 ].
Immunohistochemistry (IHC) stained positive for CD 34 [ Figure 6 ] and D2-40. Since the child was highly symptomatic and not responding to pleural fluid drainage and dietary modifications, he was treated with conformal RT to right hemithorax to a dose of 18 Gy in 12 fractions, right hemipelvis, and right thigh to a dose of 20 Gy in 11 fractions. He tolerated treatment well and showed an excellent symptomatic response to therapy with a significant reduction in his dyspneic episodes, chest and body pain. Presently, the patient is on close follow-up of over 1 year with a Karnofsky performance status of 90%, and his latest radiograph chest and abdomen showed significant radiological improvement [ Figure 7 ].
DISCUSSION
Lymphangiomatosis describes an extremely uncommon, benign congenital disorder of the lymphatic system where lymphatic channels increase in number and size and gets interconnected in an aberrant or haphazard fashion resulting in the formation of dilated sacs or cysts known as lymphangiomas [1] which invade surrounding organs or structures causing morbid conditions for the affected individual by compression or mass effect, restrictive, or obstructive mechanisms [1] by virtue of proliferation, thickening, dilatation leading to leakage causing accumulation of fluid which puts pressure on the vital organs, thus making them incapable to function properly.
The disorder has no sex predilection or familial pattern, presents in both infants and adults but is more aggressive in children with poor prognosis [1, 2] with 40% mortality as compared to adults. [3] The primary cause of death in children is an accumulation of chylous fluid composed of lymph and fats in the pleural and pericardial space causing mass effect, respiratory failure, and superadded infections. Although the exact cause of lymphangiomatosis is still unknown, the presence of vascular endothelial growth factor receptor-3 (VEGFR-3) responsible for the growth of lymphatics in high amounts in affected tissues may be a possible cause. [2] Lymphangiomatosis is a unique multi-organ disorder affecting mainly the pulmonary and skeletal system except central nervous system. [4] Our case showed a peculiar disseminated pattern with the involvement of the [4] characterized by benign-appearing lymphatic vessels and IHC positive for factor VIII-related antigen, pulmonary endothelial markers CD 31, CD 34, and lymphatic endothelial marker D2-40 which stains lymphatic channel endothelium but not the adjacent blood vessel.
Treatment of lymphangiomatosis has been predominantly symptomatic. [5] Procedures such as thoracentesis, pericardiocentesis, pleuroperitoneal shunt, sclerotherapy, and bone grafts have been used. Drugs such as thalidomide, steroids, propranolol, sirolimus, interferon alpha-2b, bisphosphonates, and VEGFR-3 inhibitor bevacizumab are used apart from total parenteral nutrition and high protein diet. Khunte et al. [6] used glucocorticoids, while we used RT that has been used in patients with pulmonary, abdominal, muscular, and cutaneous involvement with excellent results. [7, 8] Some oncologists have used 40 Gy for pelvic and 26 Gy for abdominal [7] while 20 Gy or 18 Gy for pulmonary lymphangiomatosis [7] to prevent any radiation pneumonitis or lung fibrosis. [7, 9, 10] The exact mechanism of response to radiation is not known, but it possibly results in lymphatic endothelial edema and fibrosis leading to obstruction of the abnormal lymphatic channels. [7] Most available information about diffuse lymphangiomatosis is based on sporadic case reports. This entity should always be considered in patients with lytic bone lesions accompanied by chylous effusions, especially in pediatric patients presenting with symptoms and signs of interstitial lung disease, to enable a prompt initiation of appropriate management. Emphasis should be given to treatment trials to determine long-term efficacy and safety of therapeutic modalities. We hereby recommend radiation therapy as one of the effective, noninvasive and nontoxic treatment modality.
